Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Haloperidol 5mg/1ml solution for injection ampoules
0402010J0AAACAC
|
Haloperidol | Haloperidol | Central Nervous System | 23,108 |
|
Haloperidol 5mg tablets
0402010J0AAAKAK
|
Haloperidol | Haloperidol | Central Nervous System | 22,248 |
|
Haloperidol 1.5mg tablets
0402010J0AAAJAJ
|
Haloperidol | Haloperidol | Central Nervous System | 21,561 |
|
Haloperidol 500microgram tablets
0402010J0AAAIAI
|
Haloperidol | Haloperidol | Central Nervous System | 15,665 |
|
Haloperidol 5mg/5ml oral solution sugar free
0402010J0AABCBC
|
Haloperidol | Haloperidol | Central Nervous System | 5,097 |
|
Haloperidol 10mg tablets
0402010J0AAALAL
|
Haloperidol | Haloperidol | Central Nervous System | 5,070 |
|
Haloperidol 10mg/5ml oral solution sugar free
0402010J0AAAGAG
|
Haloperidol | Haloperidol | Central Nervous System | 1,903 |
|
Haldol 2mg/ml oral solution
0402010J0BDACAG
|
Haldol | Haloperidol | Central Nervous System | 517 |
|
Haloperidol 500microgram capsules
0402010J0AAAAAA
|
Haloperidol | Haloperidol | Central Nervous System | 498 |
|
Haloperidol 200micrograms/ml oral solution sugar free
0402010J0AABNBN
|
Haloperidol | Haloperidol | Central Nervous System | 188 |
|
Haloperidol 500micrograms/5ml oral liquid
0402010J0AAA8A8
|
Haloperidol | Haloperidol | Central Nervous System | 34 |
|
Haloperidol 1mg/5ml oral liquid
0402010J0AAA7A7
|
Haloperidol | Haloperidol | Central Nervous System | 14 |
|
Halkid 200micrograms/ml oral solution
0402010J0BHAABN
|
Halkid | Haloperidol | Central Nervous System | 6 |
|
Serenace 500microgram capsules
0402010J0BEAAAA
|
Serenace | Haloperidol | Central Nervous System | 5 |
|
Haloperidol 1.5mg/5ml oral liquid
0402010J0AABBBB
|
Haloperidol | Haloperidol | Central Nervous System | 4 |
|
Haloperidol 250micrograms/5ml oral liquid
0402010J0AAA5A5
|
Haloperidol | Haloperidol | Central Nervous System | 2 |
|
Dozic 5mg/5ml oral solution
0402010J0BBAABC
|
Dozic | Haloperidol | Central Nervous System | No data available |
|
Haldol 10mg tablets
0402010J0BDABAL
|
Haldol | Haloperidol | Central Nervous System | No data available |
|
Haldol 5mg tablets
0402010J0BDAAAK
|
Haldol | Haloperidol | Central Nervous System | No data available |
|
Haldol 5mg/1ml solution for injection ampoules
0402010J0BDAEAC
|
Haldol | Haloperidol | Central Nervous System | No data available |
|
Haloperidol 2.5mg/5ml oral liquid
0402010J0AABKBK
|
Haloperidol | Haloperidol | Central Nervous System | No data available |
|
Haloperidol 200micrograms/5ml oral liquid
0402010J0AABGBG
|
Haloperidol | Haloperidol | Central Nervous System | No data available |
|
Haloperidol 20mg tablets
0402010J0AAAMAM
|
Haloperidol | Haloperidol | Central Nervous System | No data available |
|
Haloperidol 20mg/2ml solution for injection ampoules
0402010J0AAADAD
|
Haloperidol | Haloperidol | Central Nervous System | No data available |
|
Haloperidol 25micrograms/5ml oral liquid
0402010J0AABDBD
|
Haloperidol | Haloperidol | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.